Lexaria Bioscience Corp (LEXX)
3.15
+0.01
(+0.32%)
USD |
NASDAQ |
May 17, 16:00
2.99
-0.16
(-5.08%)
After-Hours: 20:00
Lexaria Bioscience Accounts Payable (Quarterly): 0.0477M for Feb. 29, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 0.0477M |
November 30, 2023 | 0.0921M |
August 31, 2023 | 0.225M |
May 31, 2023 | 1.010M |
February 28, 2023 | 0.1801M |
November 30, 2022 | 0.2309M |
August 31, 2022 | 0.1201M |
May 31, 2022 | 0.09M |
February 28, 2022 | 0.0609M |
November 30, 2021 | 0.1729M |
August 31, 2021 | 0.0599M |
May 31, 2021 | 0.1638M |
February 28, 2021 | 0.1346M |
November 30, 2020 | 0.0127M |
August 31, 2020 | 0.0451M |
May 31, 2020 | 0.0428M |
February 29, 2020 | 0.0556M |
November 30, 2019 | 0.0893M |
August 31, 2019 | 0.0315M |
May 31, 2019 | 0.0874M |
February 28, 2019 | 0.026M |
November 30, 2018 | 0.1083M |
August 31, 2018 | 0.0144M |
May 31, 2018 | 0.0625M |
February 28, 2018 | 0.0634M |
Date | Value |
---|---|
November 30, 2017 | 0.0599M |
August 31, 2017 | 0.0326M |
May 31, 2017 | 0.013M |
February 28, 2017 | 0.026M |
November 30, 2016 | 0.0739M |
August 31, 2016 | 0.09M |
May 31, 2016 | 0.0658M |
February 29, 2016 | 0.0461M |
November 30, 2015 | 0.0697M |
August 31, 2015 | 0.0331M |
May 31, 2015 | 0.0608M |
February 28, 2015 | 0.0364M |
November 30, 2014 | 0.1094M |
July 31, 2014 | 0.1499M |
April 30, 2014 | 0.1344M |
January 31, 2014 | 0.1862M |
October 31, 2013 | 0.1363M |
July 31, 2013 | 0.0981M |
April 30, 2013 | 0.0924M |
January 31, 2013 | 0.0774M |
October 31, 2012 | 0.067M |
July 31, 2012 | 0.182M |
April 30, 2012 | 0.1971M |
January 31, 2012 | 0.1221M |
October 31, 2011 | 0.3223M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.0127M
Minimum
Nov 2020
1.010M
Maximum
May 2023
0.1476M
Average
0.0897M
Median
Accounts Payable (Quarterly) Benchmarks
Sunshine Biopharma Inc | 2.586M |
Acasti Pharma Inc | 0.913M |
Aurinia Pharmaceuticals Inc | 4.327M |
Edesa Biotech Inc | -- |
Xenon Pharmaceuticals Inc | 6.43M |